The Trump administration appears to be walking back its statements from last year that the prescription drug leucovorin can be used to treat certain patients with autism.
The Food and Drug Administration on Tuesday updated the label of leucovorin, a high-dose B vitamin, to list it as a treatment for cerebral folate transport deficiency, an ultra-rare genetic condition, but not autism spectrum disorder, as administration officials promised last September.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.